Understanding bronchiectasis severity and predicting future flare-ups

This trial is testing a new assessment framework called BASE (Bronchiectasis Assessment of Severity and Exacerbations) that aims to measure how severe your bronchiectasis is right now and predict your risk of experiencing flare-ups over the next 12 months. Instead of relying on past medical records or patient memories, this assessment tool focuses on objective measurements — including how your lungs function, what imaging shows, your oxygen levels, and markers of inflammation in your body. The goal is to create a more reliable, fair way to help doctors understand your individual risk and plan better care for you.

Current ways of assessing bronchiectasis severity rely on things that can vary widely — like past hospital visits, how bad your shortness of breath feels, or previous infections — which can be influenced by factors like access to healthcare or how well things were documented. This trial exists to develop a more objective, standardized approach that focuses on measurable physical signs of disease, so doctors can better predict who will have more flare-ups and provide more personalized, proactive care.